Stay updated on Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.

Latest updates to the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision v3.3.2 was added and an older revision v3.2.0 was removed from the Record History.SummaryDifference0.1%

- Check23 days agoChange DetectedA government funding status notice was removed from the page. This notice pertained to operating status and does not affect the study's data, recruitment, or results.SummaryDifference0.8%

- Check38 days agoChange DetectedA new version (2019-12-17) was added to the record history with updates to Recruitment Status and Study Status. The version includes a Last Update timestamp.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded a government-operating-status notice and a version upgrade to v3.2.0; removed the previous v3.1.0 marker.SummaryDifference13%

- Check73 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes provided.SummaryDifference0.3%

- Check88 days agoChange DetectedUpdated the page from v3.0.1 to v3.0.2 and removed the 'Back to Top' link.SummaryDifference0.8%

Stay in the know with updates to Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.